NICE guidance on familial hypercholesterolaemia: all sugar and spice?

Heart Lung Circ. 2009 Jun;18(3):181-3. doi: 10.1016/j.hlc.2008.10.012. Epub 2008 Dec 31.

Authors

Gerald F Watts¹, Ian Hamilton-Craig, David R Sullivan

Affiliation

¹ School of Medicine and Pharmacology, Royal Perth Hospital Unit, University of Western Australia, Level 4, Medical Research Foundation Building, Rear 50 Murray Street, Perth, Western Australia 6000, Australia. gerald.watts@uwa.edu.au

PMID: 19119070
DOI: 10.1016/j.hlc.2008.10.012

No abstract available

MeSH terms

Adolescent
Adult
Australasia
Child
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hyperlipoproteinemia Type II / diagnosis*
Hyperlipoproteinemia Type II / therapy*
Middle Aged
Pedigree
Practice Guidelines as Topic*
Primary Health Care*
Risk Reduction Behavior
United Kingdom
Young Adult

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors